220 related articles for article (PubMed ID: 10702938)
21. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy.
Potter MJ; Thirkill CE; Dam OM; Lee AS; Milam AH
Ophthalmology; 1999 Nov; 106(11):2121-5. PubMed ID: 10571347
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated retinopathy associated with invasive thymoma.
Katsuta H; Okada M; Nakauchi T; Takahashi Y; Yamao S; Uchida S
Am J Ophthalmol; 2002 Sep; 134(3):383-9. PubMed ID: 12208250
[TBL] [Abstract][Full Text] [Related]
23. Cancer-associated retinopathy in a patient with endometrial cancer.
Ohkawa T; Kawashima H; Makino S; Shimizu Y; Shimizu H; Sekiguchi I; Tsuchida S
Am J Ophthalmol; 1996 Nov; 122(5):740-2. PubMed ID: 8909222
[TBL] [Abstract][Full Text] [Related]
24. [Carcinoma-associated retinopathy].
Ohguro H; Maruyama I
Ryoikibetsu Shokogun Shirizu; 2000; (31):73-6. PubMed ID: 11269192
[No Abstract] [Full Text] [Related]
25. Cancer-associated retinopathy in patients with breast carcinoma.
Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
[TBL] [Abstract][Full Text] [Related]
26. [CAR syndrome (carcinoma-associated retinopathy syndrome) associated with an adenocarcinoma of the cervix].
Seles S; Lang GE
Klin Monbl Augenheilkd; 2005 Sep; 222(9):736-9. PubMed ID: 16175485
[TBL] [Abstract][Full Text] [Related]
27. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome.
Maeda A; Ohguro H; Nabeta Y; Hirohashi Y; Sahara H; Maeda T; Wada Y; Sato T; Yun C; Nishimura Y; Torigoe T; Kuroki Y; Sato N
Eur J Immunol; 2001 Feb; 31(2):563-72. PubMed ID: 11180121
[TBL] [Abstract][Full Text] [Related]
28. [Ocular manifestations of cancer].
De Potter P; Disneur D; Levecq L; Snyers B
J Fr Ophtalmol; 2002 Feb; 25(2):194-202. PubMed ID: 11941243
[TBL] [Abstract][Full Text] [Related]
29. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice.
Maeda A; Maeda T; Ohguro H; Palczewski K; Sato N
Eur J Immunol; 2002 Aug; 32(8):2300-7. PubMed ID: 12209643
[TBL] [Abstract][Full Text] [Related]
30. Choroidal neovascularization associated with cancer-associated retinopathy.
Querques G; Thirkill CE; Hagege H; Soubrane G; Souied EH
Acta Ophthalmol; 2010 Aug; 88(5):571-5. PubMed ID: 19141145
[TBL] [Abstract][Full Text] [Related]
31. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision.
Bazhin AV; Shifrina ON; Savchenko MS; Tikhomirova NK; Goncharskaia MA; Gorbunova VA; Senin II; Chuchalin AG; Philippov PP
Lung Cancer; 2001 Oct; 34(1):99-104. PubMed ID: 11557119
[TBL] [Abstract][Full Text] [Related]
32. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
[TBL] [Abstract][Full Text] [Related]
33. A clinical triad to diagnose paraneoplastic retinopathy.
Jacobson DM; Thirkill CE; Tipping SJ
Ann Neurol; 1990 Aug; 28(2):162-7. PubMed ID: 2171418
[TBL] [Abstract][Full Text] [Related]
34. Frequent detection of anti-recoverin cytotoxic T-lymphocyte precursors in peripheral blood of cancer patients by using an HLA-A24-recoverin tetramer.
Rong S; Ikeda H; Sato Y; Hirohashi Y; Takamura Y; Sahara H; Sato T; Maeda A; Ohguro H; Sato N
Cancer Immunol Immunother; 2002 Jul; 51(5):282-90. PubMed ID: 12070715
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated retinopathy.
Goldstein SM; Syed NA; Milam AH; Maguire AM; Lawton TJ; Nichols CW
Arch Ophthalmol; 1999 Dec; 117(12):1641-5. PubMed ID: 10604671
[TBL] [Abstract][Full Text] [Related]
36. Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
Saito W; Kase S; Yoshida K; Ohguro H; Yokoi M; Iwaki H; Ohno S
Am J Ophthalmol; 2005 Nov; 140(5):942-5. PubMed ID: 16310487
[TBL] [Abstract][Full Text] [Related]
37. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
39. Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kiloDalton.
Parc CE; Azan E; Bonnel S; Sahel JA; Kaplan J; Thirkill CE
Ophthalmic Genet; 2006 Jun; 27(2):57-61. PubMed ID: 16754207
[TBL] [Abstract][Full Text] [Related]
40. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
